Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Heated hearing on insulin cap: advocates press for statewide coverage; insurers and business groups warn of mandate costs
Summary
Supporters urged lawmakers to extend a $25 monthly cap on covered insulin and diabetic supplies tested in a PERS pilot; insurers and the business community warned a statewide mandate on the commercial market would shift costs to employers and not affect self‑funded plans.
House Bill 1114, drafted to continue coverage first tested under a PERS pilot, drew extensive testimony for and against the measure in the House Government and Veterans Affairs Committee.
The bill would create a state insurance‑code provision mirroring the $25 monthly cap on covered insulin drugs and diabetic supplies that applied to the North Dakota PERS active group plan during a two‑year pilot (Senate Bill 2140). Rebecca Fricke, executive director of NDPERS, testified that PERS' pilot showed a modest plan‑level cost: the pilot's additional premium cost was 0.14% of premium and Deloitte projected continuing the coverage would cost roughly 0.12% of premium (about $1 million) for the 2025–27 biennium. Fricke told the committee the pilot produced estimated member savings of about $80.15 per affected member per month comparing year‑over‑year data and that…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
